Discover the Impact of a Selective β3-adrenergic Agonist for Effective OAB Treatment
Program Launch: January 28, 2022
Program Expiration: July 28, 2022
LUGPA Virtual Crossfire Series:
Genomic testing and mpMRI: A case-based discussion on a multimodal approach to management of localized prostate cancer
Originally aired on: December 8, 2021
Program Expiration: 7/13/2022
Challenging the Status Quo: New Androgen Deprivation Therapy (ADT) Options
Sessions On Demand:
• LHRH Agonists vs GnRH Antagonists: Setting Treatment Goals with Patients
• Practical Strategies for Multidisciplinary Management and Patient Adherence
CME event debuted Nov. 9, 2021
Program Expiration: 5/9/2022
A case-based discussion: Genomic testing for increased confidence in management of localized prostate cancer
Originally aired on: 10/1/2021
Program Expiration: April 19, 2022
Translating New Data into nmCRPC Treatment Decisions
LUGPA Crossfire (NON-CME) Event Originally aired on: 10/12/2021
Expired: 4/12/2022
CME Event: LUTS in Men: Addressing the Symptoms of OAB and BPH While Reducing Treatment Burden
Originally aired on: 2/25/2021 at 1:00PM EST
Expired: 2/25/2022
Virtual Crossfire Series:
Advanced Prostate Cancer: Incorporating Genomic Profiling and Biomarker Testing in Clinical Practice
Live Event: July 27, 2021
Program Expiration: January 27, 2022
LUGPA Virtual Crossfire Series:
nmCRPC Updates: Applying Real-world Evidence to Improve QoL and AE Management
Originally aired on: 3/5/2021
Expired: 12/31/21
Originally aired on 12/08/2020
CME Event: UTUC
Addressing Real-World Challenges of Integrating Novel Therapies for Patients with Upper Tract Urothelial Carcinoma
Expired 12/8/2021
Originally aired on 12/14/20
CME Event: 2nd Annual Virtual Summit
Optimizing Uro-Oncology Care for Patients with Metastatic and Nonmetastatic Prostate Cancer
Expired: 12/14/2021
Session 1: Utilizing Biomarkers to Navigate Treatment Decisions for Prostate Cancer Patients
Session 2: Integrating New Therapies in the Management of Nonmetastatic Castration-Resistant Prostate Cancer (nmCRPC)
Session 3: Optimizing Treatment for Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Session 4:PARP Inhibition: A New Paradigm in Prostate Cancer Care
Virtual Crossfire Series
A case-based discussion: Use of genomic testing in patients with favorable and unfavorable intermediate risk prostate cancer
Originally aired on: Wednesday, April 14, 2021
Expired: 10/14/2021
LUGPA Virtual Crossfire Series:
Genomic Profiling to Aid Therapy Selection for Metastatic Prostate Cancer Patients
Originally aired on: 3/23/2021
Program Expiration: 9/23/2021
New Data for A Treatment Option in Non-Metastatic CRPC
Expired: 8/26/2021
Originally aired on 8/13/20
CME Event!
Radioligands as a Treatment Option for Progressive Metastatic Castration Resistant Prostate Cancer (mCRPC)
and part 2: Hitting the PSMA Target: A Role for Theranostics
Expired: 8/13/2021
Originally aired on 12/09/20
LUGPA Virtual Crossfire Series
Private Equity (PE): Fad or Future?
Expired: 12/9/2021
Virtual Crossfire Series:
A Case-Based Crossfire on AEs and QoL Management in nmCRPC
Originally aired on: 6/30/2021
Expired
Originally aired on 6/16/2020
Refining Risk-Based Treatment Decisions in the Era of Kidney-Sparing Options for Upper Tract Urothelial Carcinoma
Expired : 6/16/2021
Originally aired on 12/16/2020
Crossfire Event:
A case-based discussion: Use of genomic testing in patients with low and
favorable intermediate risk prostate cancer
Expired 6/16/2021
Originally aired on 09/23/2020
LUGPA Crossfire Series
Commercial Genomic Assays for Localized Prostate Cancer: How Do They Compare?
Expired
LUGPA Crossfire Series
How Will New Data Change nmCRPC Management
Originally aired on 7/28/20
Expired 2/15/2021
Understanding Bone Health in Patients with Prostate Cancer
Originally aired on 6/16/2020
Program Expiration Date: 12/16/2020
Tap into Telehealth: Expand Your Practice Capacity Today
Originally aired on 03/26/2020
Program Expiration Date: 09/24/2020
How COVID-19 is Affecting your LUGPA Group: Candid Interviews with Dr. Neal Shore
Originally aired on 04/02/2020
Program Expiration Date: 10/02/2020
How COVID-19 is Affecting your LUGPA Group – Part II: Candid Interviews with Dr. Neal Shore
Originally aired on 04/09/2020
Program Expiration Date: 10/09/2020
A Treatment Option in non-metastatic Castration Resistant Prostate Cancer (nmCRPC)
Originally aired on 03/26/2020
Program Expiration Date: 09/24/2020
Originally aired on 08/18/2020
Crossfire Event: UTUC
Time to Change the Management of Upper Tract Urothelial Carcinoma (UTUC)
Expired 2/18/2021
LUGPA Virtual Crossfire Series
Utilizing mpMRI and Genomic Testing for Management of Low and Intermediate Risk Prostate Cancer
Expired - Originally aired on 6/4/2020
LUGPA Virtual Crossfire Series
Optimizing QOL and AE Management for nmCRPC Patients
Expired - Originally aired on 5/19/2020
Novel Imaging Tools for Prostate Cancer:
Facilitating the Management of Patients with Rising PSA and Risk of Recurrence
(Originally aired on: November 7, 2019)
Enhancing the Care of Patients with Bladder Cancer:
Making Effective Decisions Regarding Immunotherapy in the Urology Clinic
(Originally aired on: September 18, 2019)
LUGPA Virtual Crossfire Discussion and Debate Series:
Overview of Nonmetastatic CRPC and a New Treatment Option
(Non-CME | Originally aired on: August 27, 2019)
Current and Future Treatment Options for the Nonmetastatic CRPC Patient
(Originally aired on March 28, 2019)
Hormonal Therapy for Prostate Cancer: Constructing Well-Defined Clinical Decisions
Still available for CME Credit!
(Originally aired on February 5, 2019)
LUGPA FORWARD – Understanding and Overcoming Challenges faced by Early Career Urologists
(Originally aired on January 29, 2019)
